All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Alexion Pharmaceuticals Inc., of New Haven, Conn., reported 2015 revenues of $2.604 billion, representing 21 percent growth over 2014 revenues of $2.146 billion, excluding the impact of $88 million in 2014 for reimbursement of shipments in prior years.